ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of LYL314 in Aggressive Large B-Cell Lymphoma

chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....

Enrolling
Relapsed Non-Hodgkin Lymphoma
Large B-cell Lymphoma
Drug: Cyclophosphamide
Drug: Fludarabine

Phase 1, Phase 2

Lyell Immunopharma

Indianapolis, Indiana, United States of America and 16 other locations

A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma

adult patients with selected advanced or metastatic solid tumors or lymphoma. In addition to safety and tolerability, the study aims to:* de...

Enrolling
Non-Hodgkin Lymphoma
Advanced or Metastatic Solid Tumors
Drug: WTX-330

Phase 1, Phase 2

Werewolf Therapeutics

Indianapolis, Indiana, United States and 4 other locations

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Enrolling
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: ABBV-525

Phase 1

AbbVie
AbbVie

Indianapolis, Indiana, United States and 33 other locations

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

20-expressing Non-Hodgkin lymphoma....

Enrolling
Primary Mediastinal Large B Cell Lymphoma
Marginal Zone Lymphoma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 1

Acepodia Biotech

Indianapolis, Indiana, United States and 12 other locations

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin...

Enrolling
Non Hodgkin Lymphoma
Peripheral T Cell Lymphoma
Drug: CCS1477
Drug: Venetoclax

Phase 1, Phase 2

CellCentric

Indianapolis, Indiana, United States and 22 other locations

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Indianapolis, Indiana, United States and 71 other locations

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Active, not recruiting
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Doxorubicin
Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 149 other locations

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

The purpose of this study is to find out whether the study drug, LOXO-338, is safe and effective in patients with advanced blood cancer. Patients mus...

Active, not recruiting
Lymphoma, B-cell Marginal Zone
Lymphoma, Mantle-Cell
Drug: LOXO-338
Drug: Pirtobrutinib

Phase 1

Lilly
Lilly

Indianapolis, Indiana, United States and 22 other locations

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 188 other locations

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 145 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2025 Veeva Systems